MoneyWorks4Me

Samrat Pharmachem - Quaterly Results

14 Feb 2024 Evaluate
The sales slipped to Rs. 616.74 millions for the December 2023 quarter as against Rs. 838.46 millions during the year-ago period.Net profit was down at Rs. 3.44  millions against Rs. 20.96 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -83.59%.A decline of 5.34 millions was observed in the OP in the quarter ended December 2023 from 35.59 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 616.74 838.46 -26.44 1989.19 2414.64 -17.62 3106.46 2217.51 40.09
Other Income 4.21 2.80 50.36 10.65 4.50 136.67 4.78 6.33 -24.49
PBIDT 5.34 35.59 -85.00 22.00 248.65 -91.15 244.06 248.70 -1.87
Interest 2.31 6.24 -62.98 5.82 10.65 -45.35 12.32 6.74 82.79
PBDT 3.03 29.35 -89.68 16.18 238.00 -93.20 231.74 241.96 -4.22
Depreciation 1.62 1.61 0.62 4.87 4.79 1.67 6.43 5.95 8.07
PBT 1.41 27.74 -94.92 11.31 233.21 -95.15 225.31 236.01 -4.53
TAX -2.03 6.78 -129.94 3.64 59.46 -93.88 59.00 64.16 -8.04
Deferred Tax -3.11 2.79 -211.47 0.03 2.01 -98.51 -2.07 0.28 -839.29
PAT 3.44 20.96 -83.59 7.67 173.75 -95.59 166.31 171.85 -3.22
Equity 30.90 30.90 0.00 30.90 30.90 0.00 30.90 30.90 0.00
PBIDTM(%) 0.87 4.24 -79.60 1.11 10.30 -89.26 7.86 11.22 -29.95
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..